Serpanray
Drug - Serpanray
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Reserpine
Multiple ingredients are in alphabetical order.
Strength -
1MG
The potency of the active ingredient(s), Reserpine. May repeat for multiple part products.
Applicant -
PANRAY
The firm name holding legal responsibility for Serpanray. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
009391
The FDA assigned number to Serpanray. Format is nnnnnn.
Product Number -
004
The FDA assigned number to identify Serpanray. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Serpanray was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Serpanray. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Serpanray is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Panray Corp Sub Ormont Drug And Chemical Co Inc
The full name of the firm holding legal responsibility for the new application of Serpanray.
Serpanray
|
